Literature DB >> 26467784

Can Positive Resection Margin of Intra-hepatic Cholangiocarcinoma Still Provide a Survival Benefit over Systemic Chemotherapy?

Alessandro Cucchetti, Valentina Bertuzzo, Antonio Daniele Pinna.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26467784     DOI： 10.1007/s00268-015-3280-5

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  7 in total

1.  Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress.

Authors:  Shirley S Hwang; Charles B Scott; Victor T Chang; Janet Cogswell; Shanthi Srinivas; Basil Kasimis
Journal:  Cancer Invest       Date:  2004       Impact factor: 2.176

Review 2.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

Authors:  J E Siegel; M C Weinstein; L B Russell; M R Gold
Journal:  JAMA       Date:  1996 Oct 23-30       Impact factor: 56.272

3.  Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.

Authors:  Mechteld C de Jong; Hari Nathan; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Todd W Bauer; Dustin M Walters; T Clark Gamblin; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Richard D Schulick; Michael A Choti; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-07-05       Impact factor: 44.544

4.  Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria.

Authors:  Kheng Choon Lim; Vivian W Wang; Fahad J Siddiqui; Luming Shi; Edwin S Y Chan; Hong Choon Oh; Say Beng Tan; Pierce K H Chow
Journal:  Hepatology       Date:  2014-05-29       Impact factor: 17.425

5.  Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis.

Authors:  Umberto Cillo; Gaya Spolverato; Alessandro Vitale; Aslam Ejaz; Sara Lonardi; David Cosgrove; Timothy M Pawlik
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

6.  Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.

Authors:  Olivier Farges; David Fuks; Emmanuel Boleslawski; Yves-Patrice Le Treut; Denis Castaing; Alexis Laurent; Christian Ducerf; Michel Rivoire; Philippe Bachellier; Laurence Chiche; Gennaro Nuzzo; Jean Marc Regimbeau
Journal:  Ann Surg       Date:  2011-11       Impact factor: 12.969

7.  A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.

Authors:  Omar Hyder; Hugo Marques; Carlo Pulitano; J Wallis Marsh; Sorin Alexandrescu; Todd W Bauer; T Clark Gamblin; Georgios C Sotiropoulos; Andreas Paul; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Irinel Popescu; Jean-Francois Gigot; Gilles Mentha; Shen Feng; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2014-05       Impact factor: 14.766
  7 in total
  1 in total

Review 1.  Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies.

Authors:  Alessandro Cucchetti; Alberta Cappelli; Giorgio Ercolani; Cristina Mosconi; Matteo Cescon; Rita Golfieri; Antonio Daniele Pinna
Journal:  Liver Cancer       Date:  2016-09-14       Impact factor: 11.740
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.